N.E.W. Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9K Buy
442
+42
+11% +$2.28K ﹤0.01% 546
2026
Q1
$25.1K Sell
400
-300
-43% -$24K ﹤0.01% 470
2025
Q4
$66.7K Buy
700
+300
+75% +$29.4K ﹤0.01% 330
2025
Q3
$39.1K Hold
400
﹤0.01% 356
2025
Q2
$43K Sell
400
-300
-43% -$30.4K ﹤0.01% 333
2025
Q1
$70.6K Buy
+700
New +$70.5K 0.01% 313

Other funds holding BSX

N.E.W. Advisory Services's BSX Position: Q2 2026 in Review

N.E.W. Advisory Services increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $2.28K and bringing the position to 442 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

N.E.W. Advisory Services first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $70.6K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • N.E.W. Advisory Services held 442 shares of Boston Scientific worth $18.9K as of Q2 2026.
  • N.E.W. Advisory Services bought 42 Boston Scientific shares in Q2 2026, an estimated $2.28K.
  • Boston Scientific made up ﹤0.01% of N.E.W. Advisory Services's portfolio in Q2 2026, its #546 holding.
  • N.E.W. Advisory Services first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • N.E.W. Advisory Services's Boston Scientific position peaked at $70.6K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.